Porosome Therapeutics
Porosome Therapeutics is a startup headquartered in Boston, United States, founded in 2021. It has raised at least $3.6m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Porosome Therapeutics has raised at least $3.6m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Porosome Therapeutics sits inside the Boston and New England R&D ecosystem in the Global R&D Labs Directory.
Other startups in Boston
- 123 See
- 7AI
- Acta Pharmaceuticals
- Acumino
- AdvocateMH
- AI Proteins
- Amplitude Vascular Systems
- Animerra
- Anna Health
- Antares Therapeutics
- Appex Group
Related
- Innovation profile of Boston
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Porosome Therapeutics do?
Porosome Therapeutics is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Porosome Therapeutics raised?
At least $3.6m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Porosome Therapeutics based?
Porosome Therapeutics is headquartered in Boston, United States.
When was Porosome Therapeutics founded?
Porosome Therapeutics was founded in 2021.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.